ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Scott Swanson
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Swanson, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Swanson, S.
Related Collections
Right arrow Lung - cancer

Ann Thorac Surg 2006;81:1042
© 2006 The Society of Thoracic Surgeons

Original article: General thoracic

Invited commentary

Scott Swanson, MD

Mt Sinai Medical Center, 1190 5th Ave, New York, NY 10029

(Email: scott.swanson@mountsinai.org).

The first 20% of the full text of this article appears below.

The article by Mukhopadhyay and colleagues [1] investigates the mechanism for a potential new lung cancer treatment. Four nonsmall cell lung cancer lines and a normal lung fibroblast cell line were treated with Trichostatin A, a known anti-fungal agent and histone deacetylase inhibitor. The investigators . . . [Full Text of this Article]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2006 by The Society of Thoracic Surgeons.